Technology News and Research

RSS

Portable test for bird flu promises to save many lives

An easily portable device which tests for bird flu in humans promises to save lives by cutting the time it takes to spot potentially lethal cases down to a few hours.

14 Aug 2008

Advisers to Presidential candidates discuss health care proposals during online debate

Advisers to the two major presidential candidates during an online debate on the Wall Street Journal Web site discussed the effect that their health care proposals would have on the employer-sponsored health insurance market, the Journal's "Health Blog" reports.

13 Aug 2008

About 1% of HIV-positive people worldwide have been tested for tuberculosis

Only 1% of people living with HIV/AIDS worldwide have been screened for tuberculosis, according to a report recently released by the coalition Advocacy To Control TB Internationally, or ACTION, Reuters reports.

13 Aug 2008

Isis Pharmaceuticals trials C-reactive protein drug

Isis Pharmaceuticals, Inc. announced today it has initiated a Phase 1 study of ISIS 353512, an antisense drug that inhibits the production of C-reactive protein (CRP). CRP levels are frequently elevated in patients with a variety of diseases including cardiovascular disease, Crohn's disease, rheumatoid arthritis and end-stage renal disease.

13 Aug 2008

SpectraScience awarded U.S. patent for correcting image misalignment

SpectraScience, Inc. has announced that it has been awarded a patent for correcting image misalignment between at least two images in a sequence of images due at least in part to tissue sample movement. The patent, U.S. Patent No. 7,406,215, is titled "Methods and systems for correcting image misalignment."

13 Aug 2008

St. Jude Medical receives approval of first extended-life primary cell neurostimulator for treatment of chronic pain

St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of EonC, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain.

13 Aug 2008

NanoBio vaccine for hepatitis B shows promise

Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. The disease and its complications cause an estimated 1 million deaths globally each year.

13 Aug 2008

Researchers examine safety of internet prescriber service providing erectile dysfunction medications

Online Internet shopping today offers many benefits. You can research a product in the privacy of your own home and purchase most anything by clicking a mouse. But should we be allowed to buy prescription drugs via the Internet, bypassing a traditional office visit or conversation with a physician?

12 Aug 2008

Virginia Hospital Center to launch $14 million new hospital information system

Virginia Hospital Center will launch a $14 million new Hospital Information System (HIS) in 2009 that will utilize advanced information technologies (IT) to create efficiencies and orchestrate clinical best practices. The Hospital signed an agreement with Siemens Medical Solutions and will implement its powerful workflow-engineered health information solution, Soarian.

12 Aug 2008

New technology captures human movement in 3D

Researchers from the Polytechnic University of Catalonia (UPC) and the University of Lovaina (UCL), in Belgium, have presented a technique that, using two video cameras to capture human movement, makes it possible to recognize body movements and display them in three dimension on a computer, according to the journal Multimedia Tools & Applications. The method can be applied to the development of interactive video games in which gestures are made with the hands and feet.

12 Aug 2008

IMPAX sued for patent infringement on generic Ultram ER

IMPAX Laboratories, Inc. today announced Purdue Pharma Products L.P. ("Purdue"), Napp Pharmaceutical Group Ltd. ("Napp"), Biovail Laboratories International, SRL ("Biovail") and Ortho-McNeil, Inc. ("Ortho-McNeil") have filed suit for patent infringement in the United States District Court for the District of Delaware based on the Company's submission of its Abbreviated New Drug Application ("ANDA") for tramadol hydrochloride extended-release tablets (100 mg), generic of Ultram ER, to the Food and Drug Administration.

12 Aug 2008

Ulysses Pharma issued U.S. patent for novel class of antibiotics

Ulysses Pharma has announced the issuance of US Patent 7,410,974, covering its novel class of antibiotics which target drug resistant bacteria.

12 Aug 2008

Tiny, easy to insert heart pump aids critically ill patients

Cardiologists from the Heart Center at Wake Forest University Baptist Medical Center have added the world's smallest heart pump to their arsenal to help critically ill heart patients who are in advanced cardiac failure or shock. The device works by temporarily taking over the pumping function of the heart and providing time needed to initiate lifesaving interventions.

12 Aug 2008

Designer RNA fights high cholesterol, medical researchers find

Small, specially designed bits of ribonucleic acid (RNA) can interfere with cholesterol metabolism, reducing harmful cholesterol by two-thirds in pre-clinical tests, according to a new study by researchers at UT Southwestern Medical Center in collaboration with Alnylam Pharmaceuticals and the Massachusetts Institute of Technology.

11 Aug 2008

The hype around stem cells

The most common use of stem cells in the near future will be in trials testing drugs for toxicity, rather than in revolutionary medical breakthroughs, a world expert in the social effects of stem cell research says.

10 Aug 2008

New therapeutic platform technology tackles major diseases

A spin out company from basic structural biology, Asterion Ltd., has led to new technology that provides a way of creating therapeutic proteins to tackle major diseases such as cancer, diabetes and infertility.

8 Aug 2008

BioNanomatrix awarded NIH grant for nanoscale platform for single-molecule DNA mapping

BioNanomatrix, Inc. has announced receipt of a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH). Under the direction of BioNanomatrix principal investigator Dr. Ming Xiao, the two-year $399,020 project will develop a nanoscale platform for single-molecule haplotyping imaging and analysis of long strands of DNA at ultra-high resolution in a massively parallel format.

6 Aug 2008